CTMX CytomX Therapeutics Inc

USD 2.18 -0.01 -0.456621
Icon

CytomX Therapeutics Inc (CTMX) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 2.18

-0.01 (-0.46)%

USD 0.14B

2.85M

USD 2.94(+34.75%)

USD 3.00 (+37.61%)

Icon

CTMX

CytomX Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 2.18
0.00 0
Take a Tour
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.14B

USD 3.00 (+37.61%)

USD 2.18

CytomX Therapeutics Inc (CTMX) Stock Forecast

Show ratings and price targets of :
USD 2.94
(+34.75%)

Based on the CytomX Therapeutics Inc stock forecast from 3 analysts, the average analyst target price for CytomX Therapeutics Inc is USD 2.94 over the next 12 months. CytomX Therapeutics Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of CytomX Therapeutics Inc is Slightly Bearish, which is based on 4 positive signals and 6 negative signals. At the last closing, CytomX Therapeutics Inc’s stock price was USD 2.18. CytomX Therapeutics Inc’s stock price has changed by -2.68% over the past week, -14.17% over the past month and +43.42% over the last year.

No recent analyst target price found for CytomX Therapeutics Inc
No recent average analyst rating found for CytomX Therapeutics Inc

Company Overview CytomX Therapeutics Inc

CytomX Therapeutics, Inc., an oncology-focused biopharmaceutical company, focuses on developing novel conditionally activated biologics localized to the tumor microenvironment. The company utilizes conditional activation platform technology for oncology biologics research and dev...Read More

https://www.cytomx.com

151 Oyster Point Boulevard, South San Francisco, CA, United States, 94080

120

December

USD

USA

Adjusted Closing Price for CytomX Therapeutics Inc (CTMX)

Loading...

Unadjusted Closing Price for CytomX Therapeutics Inc (CTMX)

Loading...

Share Trading Volume for CytomX Therapeutics Inc Shares

Loading...

Compare Performance of CytomX Therapeutics Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for CTMX

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To CytomX Therapeutics Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc +0.69 (+0.17%) USD107.38B 29.93 21.06

ETFs Containing CTMX

Symbol Name CTMX's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About CytomX Therapeutics Inc (CTMX) Stock

Based on ratings from 3 analysts CytomX Therapeutics Inc's stock is Buy . Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 1 buy, sell and 3 hold ratings.

Unfortunately we do not have enough data on CTMX's stock to indicate if its a good dividend stock.

Based on targets from 3 analysts, the average taret price for CTMX is USD 2.94 over the next 12 months. The maximum analyst target price is USD 3.25 while the minimum anlayst target price is USD 2.5.

Unfortunately we do not have enough data on CTMX's stock to indicate if its overvalued.

The last closing price of CTMX's stock was USD 2.18.

The most recent market capitalization for CTMX is USD 0.14B.

Based on targets from 3 analysts, the average taret price for CTMX is projected at USD 2.94 over the next 12 months. This means that CTMX's stock price may go up by +34.75% over the next 12 months.

We can't find any ETFs which contains CytomX Therapeutics Inc's stock.

As per our most recent records CytomX Therapeutics Inc has 120 Employees.

CytomX Therapeutics Inc's registered address is 151 Oyster Point Boulevard, South San Francisco, CA, United States, 94080. You can get more information about it from CytomX Therapeutics Inc's website at https://www.cytomx.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...